Please login to the form below

Not currently logged in
Email:
Password:

Quanticate names chief operating officer

Alan Morgan joins the data-focused clinical research organisation

Quanticate Alan MorganLondon-based clinical research organisation Quanticate has appointed Alan Morgan as its chief operating officer.

Morgan will oversee the data-focused firm's global office network across India, Poland, South Africa, the UK and the US with a view to expanding its client base in clinical data services.

He joins from both Oxfordshire Life Sciences, a consulting and advisory service, where he served as managing director, and pharma services provider Concept Life sciences, which he co-founded in 2014 and served as its chief executive.

Previously, Morgan served as ICON's group president for clinical research services, and has held a number of finance management roles at AstraZeneca, Covance, GlaxoSmithKline, MDS and RPS.

David Underwood, chief executive of Quanticate, said: “Alan will be a real asset to both Quanticate and our customers as he will help to continue to optimize our processes while providing strategic direction for the future.

“As the clinical data experts, Alan's leadership over our operational teams will ensure the highest quality is delivered at all times to our customers and our leading position in the marketplace as a niche data-focused CRO is continually strengthened.”

7th October 2016

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....